[The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D004298:Dopamine / Q000652:urine; D004837:Epinephrine / Q000652:urine; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000652:urine; D010648:Phenylacetates / Q000652:urine; D014642:Vanilmandelic Acid / Q000652:urine
D010648:Phenylacetates; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D004837:Epinephrine
Vliianie alpha-DOPA na dinamiku ékskretsii s mochoí DOFA,katekholaminov i ikh metabolitov u zdorovykh liudeí bol'nykh parkinsonizmom.